1. Home
  2. AVTX vs GOCO Comparison

AVTX vs GOCO Comparison

Compare AVTX & GOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • GOCO
  • Stock Information
  • Founded
  • AVTX 2011
  • GOCO 2001
  • Country
  • AVTX United States
  • GOCO United States
  • Employees
  • AVTX N/A
  • GOCO N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • GOCO Specialty Insurers
  • Sector
  • AVTX Health Care
  • GOCO Finance
  • Exchange
  • AVTX Nasdaq
  • GOCO Nasdaq
  • Market Cap
  • AVTX 57.4M
  • GOCO 64.9M
  • IPO Year
  • AVTX 2015
  • GOCO 2020
  • Fundamental
  • Price
  • AVTX $7.89
  • GOCO $5.56
  • Analyst Decision
  • AVTX Strong Buy
  • GOCO Hold
  • Analyst Count
  • AVTX 7
  • GOCO 1
  • Target Price
  • AVTX $31.00
  • GOCO $18.00
  • AVG Volume (30 Days)
  • AVTX 149.3K
  • GOCO 34.7K
  • Earning Date
  • AVTX 08-11-2025
  • GOCO 08-11-2025
  • Dividend Yield
  • AVTX N/A
  • GOCO N/A
  • EPS Growth
  • AVTX N/A
  • GOCO N/A
  • EPS
  • AVTX N/A
  • GOCO N/A
  • Revenue
  • AVTX $441,000.00
  • GOCO $834,266,000.00
  • Revenue This Year
  • AVTX N/A
  • GOCO $8.51
  • Revenue Next Year
  • AVTX N/A
  • GOCO $7.19
  • P/E Ratio
  • AVTX $1.17
  • GOCO N/A
  • Revenue Growth
  • AVTX N/A
  • GOCO 13.18
  • 52 Week Low
  • AVTX $3.39
  • GOCO $5.01
  • 52 Week High
  • AVTX $16.00
  • GOCO $21.00
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 80.64
  • GOCO 41.41
  • Support Level
  • AVTX $6.21
  • GOCO $5.71
  • Resistance Level
  • AVTX $6.89
  • GOCO $6.29
  • Average True Range (ATR)
  • AVTX 0.64
  • GOCO 0.36
  • MACD
  • AVTX 0.17
  • GOCO 0.00
  • Stochastic Oscillator
  • AVTX 78.59
  • GOCO 3.23

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

Share on Social Networks: